In patients with psoriasis, the antagonism of TNF-α with etanercept also reduced the circulating levels of inflammatory and cardiovascular proteins, such as TNF-α, IL-1β, IL-6, and IL-8 [137]. The gene discussed is IL1B; the disease is psoriasis.